Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2508)
All Articles published online
|
Dec 15, 2000 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wei HS, Lu HM, Li DG, Zhan YT, Wang ZR, Huang X, Cheng JL, Xu QF. The regulatory role of AT1 receptor on activated HSCs in hepatic fibrogenesis: Effects of RAS inhibitors on hepatic fibrosis induced by CCl4. World J Gastroenterol 2000; 6(6): 824-828 [PMID: 11819703 DOI: 10.3748/wjg.v6.i6.824] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v6/i6/824.htm |
| Number | Citing Articles |
| 1 |
Guang-Jin Yuan, Ming-Liang Zhang, Zuo-Jiong Gong. Effects of PPARg agonist pioglitazone on rat hepatic fibrosis. World Journal of Gastroenterology 2004; 10(7): 1047-1051 doi: 10.3748/wjg.v10.i7.1047
|
| 2 |
William A. Blessing, Amanda K. Williamson, Jack R. Kirsch, Mark W. Grinstaff. The Prognosis of Arthrofibroses: Prevalence, Clinical Shortcomings, and Future Prospects. Trends in Pharmacological Sciences 2021; 42(5): 398 doi: 10.1016/j.tips.2021.02.007
|
| 3 |
Marcelo Ferder, Felipe Inserra, Walter Manucha, León Ferder. The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system. American Journal of Physiology-Cell Physiology 2013; 304(11): C1027 doi: 10.1152/ajpcell.00403.2011
|
| 4 |
Syeda H. Afroze, Md Kamruzzaman Munshi, Allyson K. Martínez, Mohammad Uddin, Maté Gergely, Claudia Szynkarski, Micheleine Guerrier, Damir Nizamutdinov, David Dostal, Shannon Glaser. Activation of the renin-angiotensin system stimulates biliary hyperplasia during cholestasis induced by extrahepatic bile duct ligation. American Journal of Physiology-Gastrointestinal and Liver Physiology 2015; 308(8): G691 doi: 10.1152/ajpgi.00116.2014
|
| 5 |
John S. Lubel, Chandana B. Herath, Jorge Tchongue, Josephine Grace, Zhiyuan Jia, Karen Spencer, David Casley, Peter Crowley, William Sievert, Louise M. Burrell, Peter W. Angus. Angiotensin-(1–7), an alternative metabolite of the renin–angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. Clinical Science 2009; 117(11): 375 doi: 10.1042/CS20080647
|
| 6 |
De-Sheng Xiao, Ji-Fang Wen, Jing-He Li, Zhong-Liang Hu, Hui Zheng, Chun-Yan Fu. Effect of deleted pancreatic cancer locus 4 gene transfection on biological behaviors of human colorectal carcinoma cells. World Journal of Gastroenterology 2005; 11(3): 348-352 doi: 10.3748/wjg.v11.i3.348
|
| 7 |
Yan Liu, Ichiro Shimizu, Toshihiro Omoya, Susumu Ito, Xiao-Song Gu, Ji Zuo. Protective effect of estradiol on hepatocytic oxidative damage. World Journal of Gastroenterology 2002; 8(2): 363-366 doi: 10.3748/wjg.v8.i2.363
|
| 8 |
Luis Téllez, Audrey Payancé, Eric Tjwa, María Jesús del Cerro, Lars Idorn, Stanislav Ovroutski, Ruth De Bruyne, Henkjan J. Verkade, Fabrizio De Rita, Charlotte de Lange, Annalisa Angelini, Valérie Paradis, Pierre Emmanuel Rautou, Juan Carlos García-Pagán. EASL-ERN position paper on liver involvement in patients with Fontan-type circulation. Journal of Hepatology 2023; 79(5): 1270 doi: 10.1016/j.jhep.2023.07.013
|
| 9 |
John B Dixon, Prithi S Bhathal, Julie R Jonsson, Andrew F Dixon, Elizabeth E Powell, Paul E O'Brien. Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. Journal of Hepatology 2003; 39(6): 967 doi: 10.1016/S0168-8278(03)00459-8
|
| 10 |
M Kamruzzman Munshi, Mohammad N Uddin, Shannon S Glaser. The role of the renin–angiotensin system in liver fibrosis. Experimental Biology and Medicine 2011; 236(5): 557 doi: 10.1258/ebm.2011.010375
|
| 11 |
Qing-He Nie, Guo-Rong Duan, Xin-Dong Luo, Yu-Mei Xie, Hong Luo, Yong-Xing Zhou, Bo-Rong Pan. Expression of TIMP-1 and TIMP-2 in rats with hepatic fibrosis. World Journal of Gastroenterology 2004; 10(1): 86-90 doi: 10.3748/wjg.v10.i1.86
|
| 12 |
Liu Yang, Ramón Bataller, Jennyfer Dulyx, Thomas M. Coffman, Pere Ginès, Richard A. Rippe, David A. Brenner. Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice. Journal of Hepatology 2005; 43(2): 317 doi: 10.1016/j.jhep.2005.02.034
|
| 13 |
Naglaa M El-Lakkany, Walaa El-Maadawy, Afaf Ain-Shoka, Afkar Badawy, Olfat Hammam, Fatma Ebeid. Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni. Clinical and Experimental Pharmacology and Physiology 2011; 38(10): 695 doi: 10.1111/j.1440-1681.2011.05575.x
|
| 14 |
Yan-Jun Luo, Jie-Ping Yu, Zhao-Hong Shi, Li Wang. Ginkgo biloba extract reverses CCl<sub>4</sub>–induced liver fibrosis in rats. World Journal of Gastroenterology 2004; 10(7): 1037-1042 doi: 10.3748/wjg.v10.i7.1037
|
| 15 |
Xing-Peng Wang, Ruling Zhang, Kai Wu, Liying Wu, Yuwei Dong. Angiotensin II Mediates Acinar Cell Apoptosis During the Development of Rat Pancreatic Fibrosis by AT1R. Pancreas 2004; 29(4): 264 doi: 10.1097/00006676-200411000-00004
|
| 16 |
Wilma Debernardi-Venon, Silvia Martini, Fiorella Biasi, Barbara Vizio, Angela Termine, Giuseppe Poli, Franco Brunello, Carlo Alessandria, Renato Bonardi, Giorgio Saracco, Mario Rizzetto, Alfredo Marzano. AT1 receptor antagonist Candesartan in selected cirrhotic patients: Effect on portal pressure and liver fibrosis markers. Journal of Hepatology 2007; 46(6): 1026 doi: 10.1016/j.jhep.2007.01.017
|
| 17 |
Wang-Xian Tang, Zi-Li Dan, Hong-Mei Yan, Cui-Huan Wu, Guo Zhang, Mei Liu, Qin Li, Shao-Bai Li. Experimental study of effect of Ganyanping on fibrosis in rat livers. World Journal of Gastroenterology 2003; 9(6): 1292-1295 doi: 10.3748/wjg.v9.i6.1292
|
| 18 |
Fan Xiao, Hongshan Wei, Shujing Song, Guoli Li, Chuan Song. Polymorphisms in the promoter region of the angiotensinogen gene are associated with liver cirrhosis in patients with chronic hepatitis B. Journal of Gastroenterology and Hepatology 2006; 21(9): 1488 doi: 10.1111/j.1440-1746.2006.04527.x
|
| 19 |
Fiona J. Warner, John S. Lubel, Geoffrey W. McCaughan, Peter W. Angus. Liver fibrosis: a balance of ACEs?. Clinical Science 2007; 113(3): 109 doi: 10.1042/CS20070026
|
| 20 |
Xiao-Jing Liu, Li Yang, Feng-Ming Luo, Hong-Bin Wu, Qu-Qiang. Association of differentially expressed genes with activation of mouse hepatic stellate cells by high-density cDNA mircoarray. World Journal of Gastroenterology 2004; 10(11): 1600-1607 doi: 10.3748/wjg.v10.i11.1600
|
| 21 |
Ji-Cheng Li, Shi-Ping Ding, Jian Xu. Regulating effect of Chinese herbal medicine on the peritoneal lymphatic stomata in enhancing ascites absorption of experimental hepatofibrotic mice. World Journal of Gastroenterology 2002; 8(2): 333-337 doi: 10.3748/wjg.v8.i2.333
|
| 22 |
Fiona J. Warner, Harinda Rajapaksha, Nicholas Shackel, Chandana B. Herath. ACE2: from protection of liver disease to propagation of COVID-19. Clinical Science 2020; 134(23): 3137 doi: 10.1042/CS20201268
|
| 23 |
Ramón Bataller, Erwin Gäbele, Christopher J. Parsons, Terry Morris, Liu Yang, Robert Schoonhoven, David A. Brenner, Richard A. Rippe. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats. Hepatology 2005; 41(5): 1046 doi: 10.1002/hep.20665
|
| 24 |
Xi Peng, Jin-Bin Feng, Hong Yan, Yun Zhao, Shi-Liang Wang. Distribution of nitric oxide synthase in stomach myenteric plexus of rats. World Journal of Gastroenterology 2001; 7(6): 852-854 doi: 10.3748/wjg.v7.i6.852
|
| 25 |
E. H. Forrest, D. Thorburn, E. Spence, K. A. Oien, G. Inglis, C.‐A. Smith, E. A. B. McCruden, R. Fox, P. R. Mills. Polymorphisms of the renin–angiotensin system and the severity of fibrosis in chronic hepatitis C virus infection. Journal of Viral Hepatitis 2005; 12(5): 519 doi: 10.1111/j.1365-2893.2005.00630.x
|
| 26 |
Katsuaki Satomura, Shuji Shimizu, Hirokazu Komeichi, Yasumi Katsuta, Yasukazu Omoto. Relationship Between Chymase and Fibrosis in Chronic Liver Diseases. Nihon Ika Daigaku Igakkai Zasshi 2005; 1(4): 168 doi: 10.1272/manms.1.168
|
| 27 |
Simone Moreira de Macêdo, Talita Antunes Guimarães, John David Feltenberger, Sérgio Henrique Sousa Santos. The role of renin-angiotensin system modulation on treatment and prevention of liver diseases. Peptides 2014; 62: 189 doi: 10.1016/j.peptides.2014.10.005
|
| 28 |
Wei Zhang, JinFeng Miao, PengFei Li, YanXia Wang, YuanShu Zhang. Up-regulation of components of the renin–angiotensin system in liver fibrosis in the rat induced by CCL4. Research in Veterinary Science 2013; 95(1): 54 doi: 10.1016/j.rvsc.2013.01.028
|
| 29 |
Josephine A. Grace, Chandana B. Herath, Kai Yan Mak, Louise M. Burrell, Peter W. Angus. Update on new aspects of the renin–angiotensin system in liver disease: clinical implications and new therapeutic options. Clinical Science 2012; 123(4): 225 doi: 10.1042/CS20120030
|
| 30 |
Nahla E El‐Ashmawy, Hoda A El‐Bahrawy, Maha M Shamloula, Amera O Ibrahim. Antifibrotic effect of AT‐1 blocker and statin in rats with hepatic fibrosis. Clinical and Experimental Pharmacology and Physiology 2015; 42(9): 979 doi: 10.1111/1440-1681.12446
|
| 31 |
Cansel Türkay, Özlem Yönem, Sema Arıcı, Ayhan Koyuncu, Mehmet Kanbay. Effect of Angiotensin-converting Enzyme Inhibition on Experimental Hepatic Fibrogenesis. Digestive Diseases and Sciences 2008; 53(3): 789 doi: 10.1007/s10620-007-9941-y
|
| 32 |
Li Zhang, Zhen Yang, Bao-Min Shi, Da-Peng Li, Chong-Yun Fang, Fa-Zu Qiu. Expression of local renin and angiotensinogen mRNA in cirrhotic portal hypertensive patient. World Journal of Gastroenterology 2003; 9(7): 1584-1588 doi: 10.3748/wjg.v9.i7.1584
|
| 33 |
Xiao-Zhong Wang, Li-Juan Zhang, Dan Li, Yue-Hong Huang, Zhi-Xin Chen, Bin Li. Effects of transmitters and interleukin-10 on rat hepatic fibrosis induced by CCl<sub>4</sub>. World Journal of Gastroenterology 2003; 9(3): 539-543 doi: 10.3748/wjg.v9.i3.539
|
| 34 |
Jun-Wang Xu, Jun Gong, Xin-Ming Chang, Jin-Yan Luo, Lei Dong, Zhi-Ming Hao, Ai Jia, Gui-Ping Xu. Estrogen reduces CCL4- induced liver fibrosis in rats. World Journal of Gastroenterology 2002; 8(5): 883-887 doi: 10.3748/wjg.v8.i5.883
|
| 35 |
Rui Zhu, Ling Yang, Lin Shen, Jin Ye, Jianguo Liu, Shenjun Hu. ANG II-AT1 receptor pathway is involved in the anti-fibrotic effect of β-elemene. Journal of Huazhong University of Science and Technology [Medical Sciences] 2009; 29(2): 177 doi: 10.1007/s11596-009-0208-z
|
| 36 |
Da Banghong, Cao Yang, Wei Houren, Chen Zhixin, Shui Yinbo, Li Zhongyu. Antagonistic effects of trasilast on proliferation and collagen synthesis induced by TGF-\sB2 in cultured human trabecular meshwork cellsin cultured human trabecular meshwork cells. Current Medical Science 2004; 24(5): 490 doi: 10.1007/BF02831117
|
| 37 |
Indu G. Rajapaksha, Lakmie S. Gunarathne, Peter W. Angus, Chandana B. Herath. Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options. Journal of Clinical Medicine 2021; 10(4): 702 doi: 10.3390/jcm10040702
|
| 38 |
Scott L. Friedman. Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver. Physiological Reviews 2008; 88(1): 125 doi: 10.1152/physrev.00013.2007
|
| 39 |
S. Pinto, M. Hoek, Y. Huang, P. Costet, L. Ma, J.E. Imbriglio. Comprehensive Medicinal Chemistry III. 2017; : 694 doi: 10.1016/B978-0-12-409547-2.12432-1
|
| 40 |
Shu Li, Lina Wang, Xiuchuan Yan, Qinglan Wang, Yanyan Tao, Junxia Li, Yuan Peng, Ping Liu, Chenghai Liu. Salvianolic Acid B Attenuates Rat Hepatic Fibrosis via Downregulating Angiotensin II Signaling. Evidence-Based Complementary and Alternative Medicine 2012; 2012: 1 doi: 10.1155/2012/160726
|
| 41 |
Ramón Bataller, Erwin Gäbele, Robert Schoonhoven, Terry Morris, Mark Lehnert, Liu Yang, David A. Brenner, Richard A. Rippe. Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver. American Journal of Physiology-Gastrointestinal and Liver Physiology 2003; 285(3): G642 doi: 10.1152/ajpgi.00037.2003
|
| 42 |
Natasha C. Dale, Elizabeth K. M. Johnstone, Kevin D. G. Pfleger. GPCR heteromers: An overview of their classification, function and physiological relevance. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.931573
|
| 43 |
Yong-Han Paik, Jonghwa Kim, Tomonori Aoyama, Samuele De Minicis, Ramon Bataller, David A. Brenner. Role of NADPH Oxidases in Liver Fibrosis. Antioxidants & Redox Signaling 2014; 20(17): 2854 doi: 10.1089/ars.2013.5619
|
| 44 |
Samuele De Minicis, David A. Brenner. NOX in liver fibrosis. Archives of Biochemistry and Biophysics 2007; 462(2): 266 doi: 10.1016/j.abb.2007.04.016
|
| 45 |
Moira B. Hilscher, Michael L. Wells, Sudhakar K. Venkatesh, Frank Cetta, Patrick S. Kamath. Fontan‐associated liver disease. Hepatology 2022; 75(5): 1300 doi: 10.1002/hep.32406
|
| 46 |
Shigeki Tsukada, Christopher J. Parsons, Richard A. Rippe. Mechanisms of liver fibrosis. Clinica Chimica Acta 2006; 364(1-2): 33 doi: 10.1016/j.cca.2005.06.014
|
| 47 |
Hong-Yi Zhou, Fang Wang, Lan Cheng, Li-Ying Fu, Ji Zhou, Wei-Xing Yao. Effects of tetrandrine on calcium and potassium currents in isolated rat hepatocytes. World Journal of Gastroenterology 2003; 9(1): 134-136 doi: 10.3748/wjg.v9.i1.134
|
| 48 |
Ramón Bataller, Robert F. Schwabe, Youkyung H. Choi, Liu Yang, Yong Han Paik, Jeffrey Lindquist, Ting Qian, Robert Schoonhoven, Curt H. Hagedorn, John J. Lemasters, David A. Brenner. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. Journal of Clinical Investigation 2003; 112(9): 1383 doi: 10.1172/JCI18212
|
| 49 |
Angela Douglass, Karen Wallace, Matthew Koruth, Caroline Barelle, Andrew J. Porter, Matthew C. Wright. Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy. Hepatology International 2008; 2(4) doi: 10.1007/s12072-008-9093-y
|
| 50 |
Keishi Kanno, Susumu Tazuma, Kazuaki Chayama. AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl4. Biochemical and Biophysical Research Communications 2003; 308(1): 177 doi: 10.1016/S0006-291X(03)01357-3
|
| 51 |
Jun-Wang Xu, Jun Gong, Xin-Ming Chang, Jin-Yan Luo, Lei Dong, Ai Jia, Gui-Ping Xu. Effects of estradiol on liver estrogen receptor-α and its mRNA expression in hepatic fibrosis in rats. World Journal of Gastroenterology 2004; 10(2): 250-254 doi: 10.3748/wjg.v10.i2.250
|
| 52 |
Wei Wei WANG, Xi Shan YANG, Xu LI, Jie WANG, Ye TIAN, Chuan Hong YANG, Huang Wen LAI. Changes in the expression of angiotensin II type 1 receptor in the development of liver fibrosis. Chinese Journal of Digestive Diseases 2004; 5(3): 118 doi: 10.1111/j.1443-9573.2004.00165.x
|
| 53 |
Christoph H. Österreicher, Kojiro Taura, Samuele De Minicis, Ekihiro Seki, Melitta Penz-Österreicher, Yuzo Kodama, Johannes Kluwe, Manfred Schuster, Gavin Y. Oudit, Josef M. Penninger, David A. Brenner. Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice. Hepatology 2009; 50(3): 929 doi: 10.1002/hep.23104
|
| 54 |
Qin Pan, Ding-Guo Li, Han-Ming Lu, Liang-Yong Lu, Yu-Qin Wang, Qin-Fang Xu. Antiproliferative and proapoptotic effects of somatostatin on activated hepatic stellate cells. World Journal of Gastroenterology 2004; 10(7): 1015-1018 doi: 10.3748/wjg.v10.i7.1015
|
| 55 |
Timothy J. Kendall, John P. Iredale. The Liver in Biology and Disease. Principles of Medical Biology 2004; 15: 497 doi: 10.1016/S1569-2582(04)15019-8
|
| 56 |
Rosalba Minisini, Carlo Fabris, Pierluigi Toniutto, Mario Pirisi. Combinatorial use of single nucleotide polymorphisms to help predict liver fibrosis in patients with hepatitis C infections. Expert Opinion on Medical Diagnostics 2009; 3(4): 355 doi: 10.1517/17530050902893311
|
| 57 |
Natállia Alle Parreira, Fernando Silva Ramalho, Marlei Josiele Augusto, Deisy Mara Silva, Cibele Maria Prado, Jorge Elias Júnior, Vanderlei Rodrigues, Leandra Náira Zambelli Ramalho. The comparative efficacy of renin-angiotensin system blockers in schistosomal hepatic fibrosis. Experimental Parasitology 2018; 191: 9 doi: 10.1016/j.exppara.2018.05.004
|
| 58 |
Ramón Bataller, Robert F. Schwabe, Youkyung H. Choi, Liu Yang, Yong Han Paik, Jeffrey Lindquist, Ting Qian, Robert Schoonhoven, Curt H. Hagedorn, John J. Lemasters, David A. Brenner. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. Journal of Clinical Investigation 2003; 112(9): 1383 doi: 10.1172/JCI18212
|
| 59 |
Ramón Bataller, Pau Sancho-Bru, Pere Ginês, David A. Brenner. Liver Fibrogenesis: A New Role for the Renin–Angiotensin System. Antioxidants & Redox Signaling 2005; 7(9-10): 1346 doi: 10.1089/ars.2005.7.1346
|
| 60 |
Ramón Bataller, David A. Brenner. Liver fibrosis. Journal of Clinical Investigation 2005; 115(2): 209 doi: 10.1172/JCI24282
|
| 61 |
Xiao-Fei Zhou, Qian Wang, Jian-Xin Chu, Ai-Lian Liu. Effects of retrorsine on mouse hepatocyte proliferation after liver injury. World Journal of Gastroenterology 2006; 12(9): 1439-1442 doi: 10.3748/wjg.v12.i9.1439
|
| 62 |
Alaa Al‐Kadi, Mahmoud El‐Daly, Nashwa F. G. El‐Tahawy, Mohamed Montaser A. Khalifa, Al‐Shaimaa F. Ahmed. Angiotensin aldosterone inhibitors improve survival and ameliorate kidney injury induced by sepsis through suppression of inflammation and apoptosis. Fundamental & Clinical Pharmacology 2022; 36(2): 286 doi: 10.1111/fcp.12718
|
| 63 |
Ralf Bahde, Linus Kebschull, Sandra Stöppeler, Andree Zibert, Ramsi Siaj, Jens P Hölzen, Evgeny Minin, Hartmut H.-J. Schmidt, Hans-Ullrich Spiegel, Daniel Palmes. Role of angiotensin-1 receptor blockade in cirrhotic liver resection. Liver International 2011; 31(5): 642 doi: 10.1111/j.1478-3231.2011.02493.x
|
| 64 |
Xiao-Lan Zhang, Li Liu, Hui-Qing Jiang. Salvia miltiorrhiza monomer IH764-3 induces hepatic stellate cell apoptosis <italic>via</italic> caspase-3 activation. World Journal of Gastroenterology 2002; 8(3): 515-519 doi: 10.3748/wjg.v8.i3.515
|
| 65 |
Indu Rajapaksha. Liver Fibrosis, Liver Cancer, and Advances in Therapeutic Approaches. Livers 2022; 2(4): 372 doi: 10.3390/livers2040028
|
| 66 |
Ebtehal El‐Demerdash, Omar M Abdel Salam, Seham A El‐Batran, Heba MI Abdallah, Nermeen M Shaffie. INHIBITION OF THE RENIN–ANGIOTENSIN SYSTEM ATTENUATES THE DEVELOPMENT OF LIVER FIBROSIS AND OXIDATIVE STRESS IN RATS. Clinical and Experimental Pharmacology and Physiology 2008; 35(2): 159 doi: 10.1111/j.1440-1681.2007.04797.x
|
| 67 |
J.S. Lubel, F.J. Warner, P.W. Angus. Frontiers in Research of the Renin-Angiotensin System on Human Disease. 2007; : 113 doi: 10.1007/978-1-4020-6372-5_6
|
| 68 |
Montserrat Moreno, Ramon Bataller. Cytokines and Renin-Angiotensin System Signaling in Hepatic Fibrosis. Clinics in Liver Disease 2008; 12(4): 825 doi: 10.1016/j.cld.2008.07.013
|
| 69 |
LUCIANA GIOLI‐PEREIRA, ÉCIO ALVES NASCIMENTO, EDSON LUCAS SANTOS, ADELAR BRACHT, MARIA APARECIDA JULIANO, JOÃO BOSCO PESQUERO, DURVAL ROSA BORGES, MARIA KOUYOUMDJIAN. Fate of bradykinin on the rat liver when administered by the venous or arterial route. Journal of Gastroenterology and Hepatology 2005; 20(3): 463 doi: 10.1111/j.1440-1746.2005.03580.x
|
| 70 |
Lakmie S Gunarathne, Harinda Rajapaksha, Nicholas Shackel, Peter W Angus, Chandana B Herath. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics. World Journal of Gastroenterology 2020; 26(40): 6111-6140 doi: 10.3748/wjg.v26.i40.6111
|
| 71 |
Ruobing Hao, Jun Gao, Hongwei Liu, Chenjuan Zhang, Jinpeng Huang, Jungang Fan, Jie Wei. Preventive Effect and Mechanism of Anthocyanins from Aronia Melanocarpa Elliot on Hepatic Fibrosis Through TGF-β/Smad Signaling Pathway. Cell Biochemistry and Biophysics 2022; 80(4): 737 doi: 10.1007/s12013-022-01079-z
|
| 72 |
Giselle Romero Caimi, Susana Gorzalczany, Patricia Bonazzola, Zahira Deza, María Inés Rosón, Laura Alvarez, Rocío Castilla. Angiotensin II type 1 receptor is involved in hypertension and vascular alterations caused by environmental toxicant hexachlorobenzene. Toxicology Reports 2021; 8: 1599 doi: 10.1016/j.toxrep.2021.08.009
|
| 73 |
John S Lubel, Chandana B Herath, Louise M Burrell, Peter W Angus. Liver disease and the renin–angiotensin system: Recent discoveries and clinical implications. Journal of Gastroenterology and Hepatology 2008; 23(9): 1327 doi: 10.1111/j.1440-1746.2008.05461.x
|
| 74 |
Elham Ahmadian, Peter S. Pennefather, Aziz Eftekhari, Reza Heidari, Mohammad Ali Eghbal. Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention. Expert Review of Gastroenterology & Hepatology 2016; 10(11): 1279 doi: 10.1080/17474124.2016.1207523
|
| 75 |
Eugen Florin Georgescu. Angiotensin receptor blockers in the treatment of NASH/NAFLD: Could they be a first-class option?. Advances in Therapy 2008; 25(11): 1141 doi: 10.1007/s12325-008-0110-2
|
| 76 |
Montserrat Moreno, Leandra N. Ramalho, Pau Sancho-Bru, Marta Ruiz-Ortega, Fernando Ramalho, Juan G. Abraldes, Jordi Colmenero, Marlene Dominguez, Jesús Egido, Vicente Arroyo, Pere Ginès, Ramón Bataller. Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver. American Journal of Physiology-Gastrointestinal and Liver Physiology 2009; 296(2): G147 doi: 10.1152/ajpgi.00462.2007
|
| 77 |
Ramón Bataller, David A. Brenner. Liver fibrosis. Journal of Clinical Investigation 2005; 115(2): 209 doi: 10.1172/JCI24282
|